Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Long-Term Investments: 2013-2016

Historic Long-Term Investments for Tvardi Therapeutics (TVRD) over the last 2 years, with Jun 2016 value amounting to $1.5 million.

  • Tvardi Therapeutics' Long-Term Investments rose 109.86% to $1.5 million in Q2 2016 from the same period last year, while for Jun 2016 it was $1.5 million, marking a year-over-year increase of 109.86%. This contributed to the annual value of $700,000 for FY2015, which is negligibly% changed negligibly from last year.
  • Per Tvardi Therapeutics' latest filing, its Long-Term Investments stood at $1.5 million for Q2 2016, which was down 0.00% from $1.5 million recorded in Q1 2016.
  • In the past 5 years, Tvardi Therapeutics' Long-Term Investments ranged from a high of $1.5 million in Q1 2016 and a low of $700,000 during Q4 2013.
  • Over the past 3 years, Tvardi Therapeutics' median Long-Term Investments value was $700,000 (recorded in 2015), while the average stood at $853,800.
  • Data for Tvardi Therapeutics' Long-Term Investments shows a peak YoY surged of 109.86% (in 2016) over the last 5 years.
  • Tvardi Therapeutics' Long-Term Investments (Quarterly) stood at $700,000 in 2013, then remained steady at $700,000 in 2014, then remained steady at $700,000 in 2015, then spiked by 109.86% to $1.5 million in 2016.
  • Its Long-Term Investments stands at $1.5 million for Q2 2016, versus $1.5 million for Q1 2016 and $700,000 for Q4 2015.